Boston Scientific Corp.’s Watchman improved survival in patients with erratic heart rates after four years, an unexpected finding that may help create a $500 million market, said Chief Executive Officer Michael Mahoney.
Millennial Media Inc., the seller of advertising space on smartphones that went public last year, is now 47 percent cheaper for companies such as Yahoo! Inc. and Microsoft Corp. that want to expand their share of the market.
Institutional Shareholder Services Inc., an investor advisory firm, recommended against T-Mobile USA Inc.’s merger with MetroPCS Communications Inc., dealing a blow to a transaction that lacks the support of MetroPCS’s biggest owner.
MetroPCS Communications Inc. jumped the most in two months after advisory firm Institutional Shareholder Services Inc. urged investors to block its merger with T-Mobile USA Inc., raising the prospect of a better offer.
Boston Scientific Corp. named Michael Mahoney of Johnson & Johnson its next chief executive officer as the world’s second-largest maker of implantable heart devices seeks to expand its product line and return to profitability.
Boston Scientific Corp.’s Michael Mahoney, who took the helm yesterday as chief executive officer, says innovation and smooth integration of recent acquisitions will return the company to growth next year.
Boston Scientific Corp.’s study of a heart device to reduce stroke risk, slated for presentation at a medical heart meeting this weekend, is under review after the company said only limited data about the product’s safety would be released.
Boston Scientific Corp., the second- biggest maker of heart devices, plans to cut as many as 1,000 jobs in an expansion of its restructuring program that will save an additional $100 million to $115 million a year.
MetroPCS Communications Inc., the wireless carrier looking to expand, may struggle to become a viable replacement for T-Mobile USA as AT&T Inc. tries to win government approval to buy the company from Deutsche Telekom AG.